Collaboration Details

Print  Close

Title of Collaborative Activity:

Consortium for TB Biomarkers (CTB2)

Description of Collaborative Activity:

The CTB2 seeks to establish a robust biorepository of well-documented clinical specimens to support the discovery and qualification of biomarkers of TB drug effect, especially surrogate markers for stable cure vs. relapse, and to facilitate development of rapid, reliable TB diagnostics, including tests for drug-susceptibility that would be practical for use in resource poor settings.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: